| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |